Close

Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results

Go back to Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 39.12 +0.15 (0.38%)
Previous Close $38.97    52 Week High $18.39 
Open $38.98    52 Week Low $6.96 
Day High $39.70    P/E N/A 
Day Low $38.82    EPS $-0.58 
Volume 620,516